Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5200_Библиотеки_им_академика_М_И_Перельмана
.pdf
nodules,andpersistentedemaofthecentralpartoftheface.
DIAGNOSTICCRITERIA
The diagnosis ofrosacea is based onthehistoryand clinicalpresentation.Fixed telangiectasia is the
hallmark of this disorder. Inpatients younger than age 30, acne should be ruled out.In patients with
systemic symptoms, systemic lupus erythematosus should be considered. Bacterial cultures should be
performedtoruleoutStaphylococcusaureusandgram-negativefolliculitis.Patientswhodonotrespond
tosystemicantibioticsshouldbeevaluatedforDemodexfolliculoruminfestation.Approximately50%of
patientsreportocularinvolvement,soanyocularsymptomsshouldbeinvestigated.
Referraltoanophthalmologistshouldbeconsideredifthepractitionersuspectscornealulcerationor
keratitis.
INITIATINGDRUGTHERAPY
Thegoaloftherapyistominimizethedisfiguringeffectsofrosaceaandpreventfurthertissuedamage.As
withacne,thepatient’sconcernswithregard toappearance mustbe considered. Patientswithrosacea
mayfeelstigmatized.Treatmentduringtheearlyphase(vasodilation)iseasiertotreatwiththeadditionof
topicaltherapieswithvasoconstrictiveproperties,discussedlaterinthechapter.
TopicalAntibacterials
Metronidazole
MechanismofAction
Topicalmetronidazole(MetroGel,Noritate)hasanti-inflammatoryproperties(Table15.5).Itisavailable
in0.75%and1%strengthsandis appliedonceor twice dailyinathinlayerontheface,avoiding the
eyes.
Dosage
Metronidazole is available in forms of cream, gel, and lotion. Initial results should be seen in
approximately3weeksandthefulleffectinapproximately9weeks.Patientsarethenmaintainedonthe
agent indefinitely with drug holidays as appropriate. Patients who receive concurrent anticoagulant
therapyshouldbemonitoredcloselyforanenhancedanticoagulationeffect.
TABLE15.5
OverviewofTopicalAgentsforRosacea

Contraindications
Therearenocontraindications.
SideEffects
Adverseeventsincludeburning,skinirritation,transienterythema,milddryness,andpruritus.
SpecialConsiderations
Leastexpensive generic optionsforthosewithoutinsuranceor thosewithcoveragelimitationsmaybe
recommended.
CombinationMedications
Sodium sulfacetamide 10% with sulfur 5% (Sulfacet-R, Clenia, Plexion) also has anti-inflammatory
propertieswhenusedtotreatrosacea.
Dosage
Itisappliedonetothricedailyasneededforflares.
Contraindications
Itiscontraindicatedinpatientswithkidneydisease,andcautionshouldbeexercisedinthosesensitiveto
sulfadrugs.Applicationtoeyesandareasofdenudedskinistobeavoided.

SideEffects
Adverseeventsincludelocalirritationandallergicdermatitis.
SpecialConsiderations
Rosulaisabrandedcombinationofsulfacetamide10%,sulfur5%,andurea10%.Additionofureahelps
tosootheandrelieverednessandinflammation.
AzelaicAcid
Azelaicacid15%(Finacea)isindicatedforthetopicalapplicationformildtomoderaterosacea.
Dosage
Suppliedasgelorfoamformulationappliedonceortwicedaily.Formoreinformationregardingazelaic
acid,seeacnesectionearlierinthischapter.
Antiparasitic
Ivermectin
MechanismofAction
Ivermectin1%(Soolontra)isamacrocycliclactoneworkingasatopicalanti-infective.Themechanism
ofactionisunknown.Itisusedaloneorincombinationwithotheragents.
Dosage
Itisappliedoncedailyoncleandryface.
SideEffects
Aswithanyofthetopicalagentsonsensitiveskin,localirritation,peeling,andrednessmayresult.
DecongestantsandVasoconstrictors
OxyometazolineHClCream1%(Rhofade),Brimonidine0.33%Gel(Mirvaso)
MechanismofAction
Botharealpha-adrenergic agoniststhatworkthroughdecongestionandvasoconstriction.Thisprovides
temporaryexternalconstrictiontosurfacevessels.

Dosage
Applypea-sizedamountsoncedailyinthemorningtoforehead,cheeks,nose,andchin.Thisdrugshows
benefitandmaybeeffectiveforupto8to12hours.Itis helpfulinpreventingthesevereformsofthis
condition.
Contraindications
These products arenotfor internal consumptionand for topical use only.A safetycap is providedto
prevent accidental internal consumption. Caution should be exercised in use with individuals with
glaucomaduetoincreasedincidenceriskforangleclosureglaucoma.
SideEffects
Sideeffectsincludeerythema,flushing,andburningsensations.
OralAntibiotics
When topical agents have not improved the patient’s condition, oral anti-infective agents may be
considered.
MechanismofAction
Antibioticsareusedfortheirantiinflammatoryeffectinlowerdosesasopposedtohigherdosesinacne
forantimicrobialproperties.Oralantibioticsareindicatedforpatientswithocularsymptomsandwhen
topicalagentsaloneareineffective.
Dosage
Doxycycline(Vibramycin,Monodox,Doryx,Oracea)istheantibioticofchoicefortreatingrosacea.Itis
prescribedindosesof20mgtwicedaily,50mgoncedaily,or40mgslow-releasepreparations.After3
to 5 months, the practitioner may consider discontinuing oral agent while continuing topical therapy.
Patientsshouldbecautionedtoavoidsunexposurewhiletakingdoxycyclineasdiscussedearlier.
Erythromycin (E-mycin, Ery-Tab) 250 and 500 mg is a useful agent when tetracycline is
contraindicated. Dosages and tapering regimens are identical to those used for tetracycline and are
discussedearlierinchapter.
Isotretinoin
Isotretinoinmaybeprescribed forpatientswhodo notrespondtooralandtopicalagents.Thedrugis
prescribedindoses of0.5 to1.0 mg/kg/dforupto8 months.Precautionsandlaboratoryfollow-upas
describedearlierinthischapter.
SelectingtheMostAppropriateAgent

Initialdrugtherapychoicesshouldincludeatopicalagent.Casesthatinvolveocularsymptomsshouldbe
treatedwithoralantibioticsinitially.
TABLE15.6
RecommendedOrderofTreatmentforRosacea
Order Agent Comments
Firstline Topicalmedication Improvementtakes6weeks
Secondline Oralantibiotics Improvementtakes6weeks
Thirdline Oralisotretinoin;considerreferraltodermatologist Teratogenic
First-LineTherapy
Thefirst-linetreatmentofrosaceaconsistsoftopicaltherapy.Ifnoimprovementisseenafter6weeks,
second-linetherapybegins.
Second-LineTherapy
Second-linetreatmentconsistsofaddinganoralantibiotic.After2weeks,thedoseisreducedby50%,
andthen,after6weeks,theoralantibioticisdiscontinuedaltogetherandthetopicaltreatmentcontinues
indefinitely.
Third-LineTherapy
Third-linetreatmentconsistsoforalisotretinoinorreferraltoadermatologist.Table15.6liststhelines
oftherapyforrosacea,andFigure15.2outlinesrosaceatreatment.
MONITORINGPATIENTRESPONSE
Asdiscussed throughout this chapter,thepatient’sresponse ismonitored regularlybyobservationand
follow-upvisitstoadjustmedicationsandprovidesupportandencouragementduringtherapy.
PATIENTEDUCATION
Patientswithrosaceaneedtorecognizewhattriggerstheircondition.Thegoalofmanagementistoavoid
flare-ups.Althougheachpatientrespondsdifferentlytotriggers,commontriggersaresunexposure,strong
winds,coldweather,warmenvironment,strenuousexercise,alcoholicbeverages,spicyfoods,hotfoods
andbeverages,andstress.
Itis importantthatabroad-spectrumultravioletA(UVA)/ultravioletB(UVB) sunscreenbeusedand
appliedroutinely.
Patientsmaybeadvisedtoavoidharshcleansersandavoidskinirritants.Cosmeticfoundationswitha
green tint may camouflage redness. Additional information and consumer education may be obtained
throughtheNationalRosaceaSociety(1-888-NOBLUSH,http://www.rosacea.org).

FIGURE15–2Treatmentalgorithmforrosacea.
CASESTUDY1
J.S.age16,comestoyourofficeforaroutinephysicalexamination.Younoticethatshehasfacialacne
thatsheishidingwithheavymakeup.ShehastriedClearasilinconsistentlywithoutrelief.Sheworks
atafast-foodrestaurantas a cookafterschoolandontheweekends.Her motherhasmadeherstop
eatingchocolatesandgreasyfoods,butthathasnotseemedtohelpher.Sheisconcernedbecauseher
promisin6weeksandshewantsherfaceclear.Onphysicalexamination,thereareopenandclosed
comedones,aswellaspapules,onherfaceandback.Noscarringisevident.J.S.confidesthatshehas
recentlybecomesexuallyactive.

Diagnosis:AcneVulgaris
1.ListspecifictreatmentgoalsforJ.S.
Answer: Improvement ofappearance, minimize the number andseverity oflesions, andprevent
scaring.
2.Whatdrugtherapywouldyouprescribe?Why?
Answer:Initiallytopicaltherapy. Ifthatisn'teffective, consider oralcontraceptives withethinyl
estradiolandnorgestimateordrospirenonesincesheissexuallyactive.
3.Whataretheparametersformonitoringthesuccessofthetherapy?
Answer:Responseoflesionsandappearance.
4.Describespecificpatienteducationbasedontheprescribedtherapy.
Answer:Donotuseexcessivetopicalmedicationsthinkingmoreisbetter;realizethatthetherapy
takestimetowork.
5.Listoneortwoadversereactionsfortheselectedagentthatwouldcauseyoutochangetherapy.
Answer:Severeirritationoftheskininuseoftopicalpreparation.
6.Whatwouldbethechoiceforsecond-linetherapy?
Answer:Oralantibiotics.
7.Whatover-the-counterordietarysupplementwouldyourecommendtoJ.S.?
Answer:Teatreeoil,zinc.
8.WhatdietaryandlifestylechangesshouldberecommendedforJ.S.?
Answer:Eatlowglycemicfoods.
9.Describeoneortwodrug–drugordrug–foodinteractionsfortheselectedagent.
Answer:Twotopicalpreparationsshouldnotbeusedatthesametime.
CASESTUDY2
R.K.is a 30-year-oldfemale withirregular menstrual cycles due to depo-provera. She haspainful
cystic nodules at the jawline. She has tried multiple over-the-counter (OTC) topical agents with

limited success. She has currently been using OTC salicyclic acid washes and creams due to
sensitivitytobenzylperoxide(BPO)products.
Diagnosis:AcneVulgaris
1.Whatotherquestionsregardingskincareshouldbeelicited?
Answer: It is important to elicit that the client is using proper cleansing and moisturization.
Noncomedeogenicoroil-freemakeupandskincareproductsareencouraged.Preventoverdrying
ofskinwhichcouldleadtomorelesions.
2.Whichclasswouldyouconsiderasfirst-lineagents?Whenisanappropriatetimeforafollow-up
visit?
Answer: With the knowledge of sensitivity to BPO, theremaining choices include azelaic acid
and/or topical dapsone. Prepare the client for the necessary time needed to see improvement.
Realisticexpectationsshouldbesetregardingslowimprovementover6to8weeks.Haveclients
returnsoonertoensuretheproductsarebeingused.
3. Upona returnvisit withminimal improvement,whatothertherapeutic considerationsshouldbe
discussed?Second-lineoptionsconsidered?
Answer:Atthispointconsideraddingspironolactonewhichisverybeneficialforhormone-related
painfuljawlinecysticacne.Perhapsotheroptionsofbirthcontrolcouldbeconsidered.Discussion
with an endocrinologist may also be considered. Finally, one might recommend low-dose
isotretinoinifothertherapieshavenotbeensuccessful.
4.Ifconsideringaddinganoralagent,whatwouldbeyourinitialdrugofchoice?Why?
Answer:For youngerindividuals, oralantibioticsare usuallytheoralagentofchoice;however,
womenwithcysticacnehavehadincreasedsuccessusingspironolactone.Safeforlongperiodsof
timeandminimalsideeffectsmakethisthedrugofchoice.
5.Atwhatpointisitrecommendedtoconsultwithdermatologyorconsiderchangingcontraception?
Answer: A two month follow up appointment would be warranted. If minimal improvement,
referraltodermatologyand/orchangingoralcontraceptionisrecommended
Bibliography
Barbier,J.,Chol,J.,etal.(2019). Realworlddrugusageofsurveillanceofspironolactonevsoralantibioticforthe managementoffemale
patientswithacne.JournalofAmericanAcademyofDermatology,81(3),848–851.
Bobonich,M.,&Nolen,M.(2015).Dermatologyforadvancedpracticeclinicians.Philadelphia,PA:WoltersKluwer.
Burris, J., Rietkerk, W., & Woolf, K. (2013). Acne: The role of medical nutrition therapy. Journal of the Academy of Nutrition and
Dietetics,113(3),416–430.
Friedman,A.(2015).SpironolactoneforadultfemaleAcne.Cutis,96(4),216–217.

Grove, G., Zerweck, C., & Gwazdauskas, J. (2013). Tolerabilityand irritation potential of fourtopical acne regimens in healthy subjects.
JournalofDrugsinDermatology,12(6),644–649.
Habif,T.,Dinulos,J.,Chapman,M.S.,&Zug,K.A.(2018).Sk indisease:Diagnosisandtreatment.NewYork:Elsevier.
Leyden,J.,Berk,D.,et al.(2017).Efficacy tosafetyoforalsarecycline forthetreatmentofmoderatetosevere facialacne. Journal of
AmericanAcademyofDermatology,6(6),AB113.
Maloney,M.,&Stone,S. (2011).IsotretinoinandIPledge:Aviewofresults.JournalofAmericanAcademyofDermatology,65(2),418–
419.
Saint-Jean,M.,et al.(2019). Adultacne in womenisnotassociated witha specifictype of Cutibacteriumacnes. Journal of American
AcademyofDermatology,81(3),851–852.
Snyder,S.,Crandell,I.,Davis,S.A.,etal.(2014).Medicaladherencetoacnetherapy:Asystematicreview.AmericanJournalofClinical
Dermatology,15(2),87–94.
Thiboutot,D.,etal.(2016).Oncedailytopicaldapsonegel7.5%forAcneVulgaris.JournalofAmericanAcademyofDermatology,74(5),
AB7.
Zaenglein, A., Pathy, A., et al. (2016). Guidelines of care for the management of acne vulgaris. Journal of American Academy of
Dermatology,74(5),945–973.

UNIT
4
PharmacotherapyforEyeandEarDisorders
Соседние файлы в папке Библиотека им академика М.И. Перельмана
